Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 11.02.19 in Vol 8, No 2 (2019): February

This paper is in the following e-collection/theme issue:

Works citing "A Novel Smoking Cessation Smartphone App Integrated With a Mobile Carbon Monoxide Checker for Smoking Cessation Treatment: Protocol for a Randomized Controlled Trial"

According to Crossref, the following articles are citing this article (DOI 10.2196/12252):

(note that this is only a small subset of citations)

  1. Masaki K, Tateno H, Nomura A, Muto T, Suzuki S, Satake K, Hida E, Fukunaga K. A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker. npj Digital Medicine 2020;3(1)
    CrossRef
  2. Nomura A, Tanigawa T, Muto T, Oga T, Fukushima Y, Kiyosue A, Miyazaki M, Hida E, Satake K. Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial. Journal of Medical Internet Research 2019;21(4):e13520
    CrossRef
  3. Marsch LA. Digital health and addiction. Current Opinion in Systems Biology 2020;20:1
    CrossRef
  4. Tanigawa T, Nomura A, Kuroda M, Muto T, Hida E, Satake K. Comparing Telemedicine and Face-to-Face Consultation Based on the Standard Smoking Cessation Program for Nicotine Dependence: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2019;8(7):e12701
    CrossRef
  5. Kario K, Nomura A, Harada N, Tanigawa T, So R, Nakagawa K, Suzuki S, Okura A, Hida E, Satake K. A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB‐DH1 trial. The Journal of Clinical Hypertension 2020;
    CrossRef